MedLogic Global buys UK factory:
This article was originally published in Clinica
MedLogic Global has bought a factory in Plymouth, UK to develop hydrogel polymer and adhesive products for rapid introduction into the European market. The factory was bought from US company VidaMed and the UK government will provide milestone payments of £500,000 dependent on job creation at the plant. MedLogic is a privately-owned US wound closure company, founded in 1991. Last month it purchased the assets of Gel Sciences, with its hydrogel polymer technology. MedLogic says that obtaining manufacturing facilities was a key part of its European market entry strategy.
You may also be interested in...
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”
The Onyx One Clear study, evaluating the Resolute Onyx drug-eluting stent in high bleeding risk patients, met its primary endpoint at the one-year follow up.